4.7 Review

RNA toxicity in human disease and animal models: From the uncovering of a new mechanism to the development of promising therapies

期刊

出版社

ELSEVIER
DOI: 10.1016/j.bbadis.2013.03.002

关键词

Animal model; RNA toxicity; Trinucleotide repeat; Microsatellite expansion; Myotonic dystrophy; RNA splicing

资金

  1. AFM (Association Francaise contre les Myopathies, France)
  2. ANR (Agence Nationale de Recherche, France)
  3. INSERM (Institut National de la Sante et Recherche Medicale, France)
  4. Universite Paris Descartes (Paris, France)
  5. French Ministry for Higher Education and Research
  6. AFM

向作者/读者索取更多资源

Mutant ribonucleic acid (RNA) molecules can be toxic to the cell, causing human disease through trans-acting dominant mechanisms. RNA toxicity was first described in myotonic dystrophy type 1, a multisystemic disorder caused by the abnormal expansion of a non-coding trinucleotide repeat sequence. The development of multiple and complementary animal models of disease has greatly contributed to clarifying the complex disease pathways mediated by toxic RNA molecules. RNA toxicity is not limited to myotonic dystrophy and spreads to an increasing number of human conditions, which share some unifying pathogenic events mediated by toxic RNA accumulation and disruption of RNA-binding proteins. The remarkable progress in the dissection of disease pathobiology resulted in the rational design of molecular therapies, which have been successfully tested in animal models. Toxic RNA diseases, and in particular myotonic dystrophy, clearly illustrate the critical contribution of animal models of disease in translational research: from gene mutation to disease mechanisms, and ultimately to therapy development. This article is part of a Special Issue entitled: Animal Models of Disease. (C) 2013 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据